Travere Therapeutics (TVTX)

• Market cap: $2.44B
• 1 day: -0.69%
• 5 days: 8.54%
• 1 month: 15.52%
• 3 months: 65.48%
• 6 months: 83.11%
• Year to date: 44.02%
• 1 year: 49.7%
• 5 years: 27.72%
• 10 years: 42.74%
• Sector: Healthcare
• Industry: Biotechnology

About: Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Employees: 385